Shareholder Votes

FRESH DEL MONTE PRODUCE INC shareholders approved Advisory vote to approve compensation of named executive officers for 2025 at the 2026-06-04 meeting.

“The shareholders approved, by a non-binding, advisory vote, the compensation of the Company’s named executive officers in 2025. For Against Abstain Broker Non-Votes 41,601,422 1,580,590 30,183 1,564,081”

FRESH DEL MONTE PRODUCE INC shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-06-04 meeting.

“The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. For Against Abstain 43,705,679 1,057,380 13,217”

FRESH DEL MONTE PRODUCE INC shareholders approved Election of two director nominees for a three-year term expiring at the 2029 Annual General Meeting at the 2026-06-04 meeting.

“The shareholders approved the election of two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders. Directors For Against Abstain Broker Non-Votes Michael J. Berthelot 33,949,696 9,251,545 10,954 1,564,081 Lori Tauber Marcus 36,934,077 6,267,439 10,680 1,564,081”

Open Lending Corp shareholders approved Reverse Stock Split Proposal - Amendment to Certificate of Incorporation to effect a reverse stock split at a ratio in the range from 1-for-5 to 1-for-7 at the 2026-06-03 meeting.

“Proposal 5 - Reverse Stock Split Proposal The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s shares of common stock at a ratio in the range from 1-for-5 to 1-for-7, and a proportionate decrease to the number of authorized shares of the Company’s common stock, with the exact ratio to be set within such range at the discretion of the Company’s board of directors without further action by the Company’s stockholders.”

Open Lending Corp shareholders approved Stockholder Proposal Regarding the Declassification of the Company’s Board of Directors at the 2026-06-03 meeting.

“Proposal 4 - Stockholder Proposal Regarding the Declassification of the Company’s Board of Directors The stockholders approved the stockholder proposal regarding the declassification of the Company’s board of directors.”

Open Lending Corp shareholders approved Nonbinding Advisory Vote Approving the Compensation of the Company’s Named Executive Officers at the 2026-06-03 meeting.

“Proposal 3 - Nonbinding Advisory Vote Approving the Compensation of the Company’s Named Executive Officers The stockholders approved the compensation of the Company’s named executive officers.”

Open Lending Corp shareholders approved Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“Proposal 2 - Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Open Lending Corp shareholders approved Election of Two Class III Director Nominees at the 2026-06-03 meeting.

“Proposal 1 - Election of Two Class III Director Nominees The stockholders elected each of the two persons named below to serve as Class III members of the Company’s board of directors, to serve until the Company’s 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified.”

Kodiak Sciences Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was ratified. For Against Abstain Broker Non-Votes 54,716,676 52,962 256,906 —”

Kodiak Sciences Inc. shareholders approved Advisory Approval of the Compensation of Named Executive Officers at the 2026-06-02 meeting.

“The compensation of the Company’s named executive officers was approved, on an advisory basis, by the stockholders. For Against Abstain Broker Non-Votes 49,157,143 323,196 21,005 5,525,200”

Kodiak Sciences Inc. shareholders approved Election of Class II Directors at the 2026-06-02 meeting.

“The following nominees were each elected as a Class II director to serve until the 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified. Nominee For Withheld Broker Non-Votes Charles A. Bancroft 38,940,529 10,560,815 5,525,200 Bassil I. Dahiyat, Ph.D. 48,843,144 658,200 5,525,200 Taiyin Yang, Ph.D. 49,192,610 308,734 5,525,200”

Arteris, Inc. shareholders approved Ratification of the selection of Deloitte & Touche, LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-06-02 meeting.

“The ratification of the selection by the audit committee of the board of directors of the Company of Deloitte & Touche, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 36,095,687 145,040 9,284”

Arteris, Inc. shareholders approved Election of three Class II directors to hold office until the 2029 annual meeting at the 2026-06-02 meeting.

“The election of three Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successor is elected: Nominee Votes For Votes Withheld Broker Non-Votes Antonio J. Viana 24,909,978 8,213,781 3,126,251 Wayne C. Cantwell 26,200,856 6,922,903 3,126,251 Joachim Kunkel 27,178,951 5,944,808 3,126,251”

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Approval of Amendment to the 2020 Equity Incentive Plan at the 2026-06-03 meeting.

“Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan For Against Abstain Broker Non-Votes 114,865,820 20,469,132 1,896,112 65,778,311 The stockholders approved the amendment to the 2020 Plan”

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Advisory Vote on Approval of Named Executive Officer Compensation at the 2026-06-03 meeting.

“Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation For Against Abstain Broker Non-Votes 114,050,930 21,239,989 1,940,145 65,778,311 The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 198,046,666 3,990,483 972,226 — The stockholders ratified the appointment of Ernst & Young LLP”

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Election of Four Class III Directors at the 2026-06-03 meeting.

“Proposal 1: Election of Four Class III Directors Name of Director For Against Abstain Broker Non-Votes William Ericson 128,010,323 8,109,601 1,111,140 65,778,311 Kathy Ordoñez 130,522,400 5,673,816 1,034,848 65,778,311 Christopher M. Smith 131,731,235 4,069,337 1,430,492 65,778,311 Chris Gibson, Ph.D. 131,899,750 4,107,270 1,224,044 65,778,311 Christian O. Henry 129,999,918 5,924,115 1,307,031 65,778,311 John F. Milligan, Ph.D. 130,471,635 5,650,906 1,108,523 65,778,311 Each director nominee was duly elected”

Tango Therapeutics, Inc. shareholders approved Non-binding advisory vote to approve named executive officer compensation at the 2026-06-04 meeting.

“The Company's stockholders approved the non-binding, advisory vote on the compensation of the Company's named executive officers.”

Tango Therapeutics, Inc. shareholders approved Ratification of the selection of PricewaterhouseCoopers, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“The selection of PricewaterhouseCoopers, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.”

Tango Therapeutics, Inc. shareholders approved Election of Mace Rothenberg, M.D. as Class II director at the 2026-06-04 meeting.

“Malte Peters, M.D. and Mace Rothenberg, M.D. were duly elected to the Company's Board as Class II directors.”

Tango Therapeutics, Inc. shareholders approved Election of Malte Peters, M.D. as Class II director at the 2026-06-04 meeting.

“Malte Peters, M.D. and Mace Rothenberg, M.D. were duly elected to the Company's Board as Class II directors.”

Satellogic Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accountants at the 2026-06-03 meeting.

“Proposal 2: The appointment of Ernst & Young LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2026 was ratified. For Against Abstain Non-Votes 88,296,497 77,298 333,795 N/A”

Satellogic Inc. shareholders approved Election of Class II Directors at the 2026-06-03 meeting.

“Proposal 1: The Class II nominees were elected to serve as Class II directors for terms expiring at the 2029 annual meeting of stockholders. For Withheld Non-Votes Tom Killalea 53,089,642 11,114,805 24,504,143 Miguel Gutierrez 57,976,060 6,228,387 24,504,143”

SERA PROGNOSTICS, INC. shareholders approved Ratification of Ernst & Young LLP as Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“2. Auditor Ratification Shares Voted For Shares Voted Against Shares Abstaining Broker Non-votes 24,917,046 856,113 44 —”

SERA PROGNOSTICS, INC. shareholders approved Election of Class II Directors at the 2026-06-04 meeting.

“1. Election of Directors Nominee Shares Voted For Shares Voted to Withhold Authority Broker Non-votes Kim Kamdar, Ph.D. 9,749,623 3,062,352 12,961,228 Sandra A. J. Lawrence 12,483,966 328,009 12,961,228”

USA Rare Earth, Inc. shareholders approved Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Thomas Caulfield 84,594,718 — 420,894 48,822,033 Barbara Humpton 84,539,571 — 476,041 48,822,033 Otto Schwethelm 77,107,170 — 7,908,442 48,822,033 Michael Senft 79,884,823 — 5,130,789 48,822,033 Carolyn Trabuco 73,238,170 — 11,777,442 48,822,033 Proposal 2 – Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

USA Rare Earth, Inc. shareholders approved Election of six directors at the 2026-06-03 meeting.

“The stockholders elected six (6) Directors of the Board to serve for a one-year term until the Company’s 2027 Annual Meeting of Stockholders or a respective successor is elected and qualified or until the director’s earlier death, resignation, or removal.”

ANTERO RESOURCES Corp shareholders approved Advisory vote to approve the compensation of the Company's named executive officers at the 2026-06-03 meeting.

“Proposal No. 3 — Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers : The voting results were as follows: For Against Abstain Broker Non-Votes 224,923,971 10,613,627 470,323 27,230,200”

ANTERO RESOURCES Corp shareholders approved Ratification of the Appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal No. 2 — Ratification of the Appointment of KPMG LLP : The voting results were as follows: For Against Abstain Broker Non-Votes 259,193,326 3,761,323 283,472 0”

ANTERO RESOURCES Corp shareholders approved Election of Class I Directors at the 2026-06-03 meeting.

“Proposal No. 1 - Election of Class I Directors : Votes regarding the persons elected as Class I directors were as follows: Nominee For Withheld Broker Non-Votes Brenda R. Schroer 215,882,118 20,125,803 27,230,200 Thomas B. Tyree, Jr. 202,552,613 33,455,308 27,230,200”

TUCOWS INC /PA/ shareholders approved Ratification of Appointment of Independent Auditors at the 2026-06-02 meeting.

“Proposal 3. Ratification of Appointment of Independent Auditors The Company’s shareholders voted upon and ratified the appointment of Deloitte LLP as the independent auditors of the Company and its subsidiaries for the fiscal year ending December 31, 2026. For Against Abstain 8,046,168 2,080 25,653”

TUCOWS INC /PA/ shareholders approved Non-binding advisory vote on the Compensation of Named Executive Officers at the 2026-06-02 meeting.

“Proposal 2. Non-binding Advisory vote on the Compensation of Named Executive Officers The Company’s shareholders voted upon and approved, on a non-binding basis, the compensation of the Company’s named Executive Officers as disclosed in the Proxy Statement. For Against Abstain 6,778,876 624,527 2,320 There were 668,178 broker non-votes with respect to the Non-binding advisory vote on Named Executive Officer Compensation”

TUCOWS INC /PA/ shareholders approved Election of Directors at the 2026-06-02 meeting.

“Proposal 1. Election of Directors The Company’s shareholders voted upon and elected the following nominees to serve on the Company’s Board of Directors for a term of one year expiring at the 2027 Annual Meeting of Shareholders. Nominee for Director Votes For Authority Withheld Marlene Carl 6,777,982 627,741 Lee Matheson 6,705,717 700,006 Sandra Matz 7,331,744 73,979 Laurenz Malte Nienaber 6,243,490 1,162,233 Allen Taylor 6,830,376 575,347 Jeffrey Tory 7,369,190 36,533 Stephen Uhrenbacher 6,764,168 641,555 David Woroch 6,831,227 574,496 There were 668,178 broker non-votes with respect to the election of directors.”

Antero Midstream Corp shareholders approved Approval, on an advisory basis, of the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2026-06-03 meeting.

“Proposal No. 4 — Approval, on an Advisory Basis, of the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers : The voting results were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 380,325,942 1,797,979 13,018,278 540,713 40,840,729”

Antero Midstream Corp shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-03 meeting.

“Proposal No. 3 — Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers : The voting results were as follows: For Against Abstain Broker Non-Votes 380,665,343 14,131,349 886,220 40,840,729”

Antero Midstream Corp shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm at the 2026-06-03 meeting.

“Proposal No. 2 — Ratification of the Appointment of KPMG LLP : The voting results were as follows: For Against Abstain Broker Non-Votes 435,213,596 913,746 396,299 0”

Antero Midstream Corp shareholders approved Election of three Class I directors at the 2026-06-03 meeting.

“Votes regarding the persons elected as Class III directors were as follows: Nominee For Withheld Broker Non-Votes Peter A. Dea 384,780,244 10,902,668 40,840,729 W. Howard Keenan, Jr. 325,136,897 70,546,015 40,840,729 Janine J. McArdle 383,264,690 12,418,222 40,840,729”

PATTERSON UTI ENERGY INC shareholders approved To cast a vote to approve, on an advisory basis, the Company’s compensation of its named executive officers as set forth in the proxy statement for the Annual Meeting. at the 2026-06-04 meeting.

“To cast a vote to approve, on an advisory basis, the Company’s compensation of its named executive officers as set forth in the proxy statement for the Annual Meeting.”

PATTERSON UTI ENERGY INC shareholders approved To approve an amendment to the Patterson-UTI Energy, Inc. 2021 Long-Term Incentive Plan. at the 2026-06-04 meeting.

“To approve an amendment to the Patterson-UTI Energy, Inc. 2021 Long-Term Incentive Plan.”

PATTERSON UTI ENERGY INC shareholders approved To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-04 meeting.

“To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

PATTERSON UTI ENERGY INC shareholders approved Election of ten directors to the Company's Board of Directors at the 2026-06-04 meeting.

“To elect ten directors to the Company’s Board of Directors to serve until the next annual meeting of the stockholders or until their respective successors are elected and qualified.”

Chime Financial, Inc. shareholders approved Select, on a non-binding advisory basis, whether future advisory votes on the compensation of the Company's named executive officers should be held every one, two, or three years at the 2026-06-02 meeting.

“(4) Proposal to select, on a non-binding advisory basis, whether future advisory votes on the compensation of the Company’s named executive officers should be held every one, two, or three years: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 691,498,616 17,654 209,974 987,505 120,030,740 Based on the votes set forth above, the stockholders advised that they were in favor of every one year”

Chime Financial, Inc. shareholders approved Approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers at the 2026-06-02 meeting.

“(3) Proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 685,837,192 6,658,614 217,943 120,030,740 Based on the votes set forth above, the stockholders approved”

Chime Financial, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

“(2) Proposal to ratify Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain 812,274,646 316,594 153,249 Based on the votes set forth above, the stockholders ratified the appointment”

Chime Financial, Inc. shareholders approved Election of three Class I directors at the 2026-06-02 meeting.

“(1) Proposal for the election of three Class I directors: For Against Abstain Broker Non-Votes Christopher Britt 669,932,083 22,666,650 115,016 120,030,740 Shawn Carolan 691,382,248 1,170,676 160,825 120,030,740 James Dunne 667,719,395 24,832,777 161,577 120,030,740 Based on the votes set forth above, each director nominee was duly elected”

Aclarion, Inc. shareholders approved Approval of an amendment to our 2022 equity incentive plan at the 2026-06-04 meeting.

“Proposal 3 – Approval of an amendment to our 2022 equity incentive plan Votes For Votes Against Abstain Broker Non-Votes 453,431 323,512 1,302 841,751 Proposal 3 was approved.”

Aclarion, Inc. shareholders approved Ratification of appointment of independent registered accounting firm – Haynie & Company at the 2026-06-04 meeting.

“Proposal 2 – Ratification of appointment of independent registered accounting firm – Haynie & Company Votes For Votes Against Abstain Broker Non-Votes 1,588,388 20,623 10,985 N/A Proposal 2 was approved.”

Aclarion, Inc. shareholders approved Election of seven directors to serve a term ending at the 2027 annual meeting at the 2026-06-04 meeting.

“Proposal 1 – Election of seven directors to serve a term ending at the 2027 annual meeting, in each case until their respective successors are duly elected and qualified. Nominee Votes For Withheld Broker Non-Votes Jeffrey Thramann 532,591 245,654 841,750 Brent Ness 528,080 250,165 841,750 Stephen Deitsch 532,578 245,668 841,750 Scott Breidbart 525,005 253,240 841,750 David Neal 468,385 309,861 841,750 William Wesemann 528,981 249,265 841,750 Amanda Williams 533,055 245,190 841,750 All seven director nominees were duly elected.”

LifeStance Health Group, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2026-06-02 meeting.

“Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company’s named executive officer compensation. The results of the vote were as follows: For Against Abstain Broker Non-Votes 322,904,359 5,675,861 354,151 29,782,714”

LifeStance Health Group, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 2: Ratification of the Company’s Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2026. The results of the vote were as follows: For Against Abstain 357,756,707 209,431 750,947”